Literature DB >> 23858805

Collagen type I alpha 1 gene polymorphism in premature ovarian failure.

Svetlana Vujović1, Selma Kanazir, Miomira Ivović, Milina Tancić-Gajić, Milka Perović, Svetlana Baltić, Ljiljana Marina, Marija Barać, Maja Ivanisević, Jelena Micić, Dragan Micić.   

Abstract

INTRODUCTION: Premature ovarian failure (POF) is characterized by amenorrhea, hypergonadotropism and hypoestrogenism in women bellow 40 years. Osteoporosis is one of the late complications of POF.
OBJECTIVE: To correlate collagen type I alpha1 (COLIA1) gene polymorphism with bone mineral density (BMD) in women with POF.
METHODS: We determined the COLIA1 genotypes SS, Ss, ss in 66 women with POF. Single nucleotide polymorphism (G toT substitution) within the Sp 1-binding site in the first intron of the COLIA1 gene was assessed by polymerase chain reaction (PCR) followed by single-stranded conformation polymorphism (SSCP) analysis. Bone mineral density (BMD) was measured at the lumbar spine region by dual X-ray absorptiometry. STATISTICS: Kruskal-Wallis ANOVA, Chi-square test, Spearman correlation test.
RESULTS: The relative distribution of COLIA1 genotype alleles was SS - 54.4%, Ss - 41.0% and ss - 4.5%. No significant differences were found between genotype groups in body mass index, age, duration of amenorrhea or BMD. A significant positive correlation was observed between BMI and parity.
CONCLUSION: The COLIA1 gene is just one of many genes influencing bone characteristics. It may act as a marker for differences in bone quantity and quality, bone fragility and accelerated bone loss in older women. However, in young women with POF, COLIA1 cannot identify those at higher risk for osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23858805     DOI: 10.2298/sarh1306344v

Source DB:  PubMed          Journal:  Srp Arh Celok Lek        ISSN: 0370-8179            Impact factor:   0.207


  1 in total

1.  Tripterygium glycosides induce premature ovarian failure in rats by promoting p53 phosphorylation and activating the serine/threonine kinase 11-p53-p21 signaling pathway.

Authors:  T E Liu; Lina Zhang; Suwei Wang; Chuan Chen; Jin Zheng
Journal:  Exp Ther Med       Date:  2015-05-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.